bt_bb_section_bottom_section_coverage_image

RareLab

Blending research with novel solutions to created needed positive change.

The Need

Innovation in rare diseases can stall due to the high risk associated with new ideas. Many promising concepts are abandoned in favor of established, yet potentially ineffective, approaches.

RareLab provides a safe space to experiment and de-risk innovation. By validating concepts before significant investment, we accelerate the development of impactful solutions. Our platform supports both internally originated and externally sourced projects.

We partner with innovators to pilot their ideas, providing expertise, resources, and a structured environment to test their viability.

Our team of experienced professionals, including subject matter experts and individuals with lived experience, drives these initiatives. Through our pilot programs, we identify promising concepts that can be scaled into standalone organizations or integrated into existing programs or organizations.

bt_bb_section_bottom_section_coverage_image
https://rarerising.org/wp-content/uploads/2024/09/RareLab-3.png

Current RareLab Pilot Programs

Click on the link below to learn more about each of our RareLab Pilot Programs.
bt_bb_section_top_section_coverage_image
bt_bb_section_bottom_section_coverage_image

RareLab Collaborative Research and Reports

Learn more about novel projects we have partners on to advance our collective understanding, fill existing gaps and resources, and identify recommendations for future improvement in rare disease.

Health Equity in the Hemophilia B Community: Perspectives of Patients’ Report Findings
Collaboration between Coalition for Hemophilia B and RareRising

A Report of Survey Findings: Diversity, Equity and Inclusion in Rare Disease Organizations
Collaboration between the Rare Disease Diversity Coalition and RareRising (formerly Upequity)

The Circle of Care Guidebook for Caregivers of Children with Rare and/or Serious Illnesses
Produced by the National Alliance for Caregivers
*RareRising Board Member Mousumi Bose, PhD and CEO Kimberly Haugstad, MBA, and Theresa Smith, LPN authored the guidebook

RDDC_Survey_Diversity_Equity_and_Inclusion_20230228
NAC_RareCaregivers_Guidebook_FINAL
HealthEquity-CHBReport-Spanish-20250225
HealthEquity-CHBReport-20250225

We welcome the opportunity to explore new research project ideas. Contact us to discuss and collaborate!

bt_bb_section_top_section_coverage_image
bt_bb_section_bottom_section_coverage_image